Your browser doesn't support javascript.
loading
Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor Thrombosis.
Kodama, Kenichiro; Kawaoka, Tomokazu; Aikata, Hiroshi; Uchikawa, Shinsuke; Nishida, Yuno; Inagaki, Yuki; Hatooka, Masahiro; Morio, Kei; Nakahara, Takashi; Murakami, Eisuke; Tsuge, Masataka; Hiramatsu, Akira; Imamura, Michio; Kawakami, Yoshiiku; Masaki, Keiichi; Honda, Yoji; Mori, Nami; Takaki, Shintaro; Tsuji, Keiji; Kohno, Hirotaka; Kohno, Hiroshi; Moriya, Takashi; Nonaka, Michihiro; Hyogo, Hideyuki; Aisaka, Yasuyuki; Kimura, Tomoki; Nagata, Yasushi; Chayama, Kazuaki.
Affiliation
  • Kodama K; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Hiroshima University, Hiroshima, Japan.
  • Kawaoka T; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Hiroshima University, Hiroshima, Japan.
  • Aikata H; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Hiroshima University, Hiroshima, Japan.
  • Uchikawa S; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Hiroshima University, Hiroshima, Japan.
  • Nishida Y; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Hiroshima University, Hiroshima, Japan.
  • Inagaki Y; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Hiroshima University, Hiroshima, Japan.
  • Hatooka M; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Hiroshima University, Hiroshima, Japan.
  • Morio K; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Hiroshima University, Hiroshima, Japan.
  • Nakahara T; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Hiroshima University, Hiroshima, Japan.
  • Murakami E; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Hiroshima University, Hiroshima, Japan.
  • Tsuge M; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Hiroshima University, Hiroshima, Japan.
  • Hiramatsu A; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Hiroshima University, Hiroshima, Japan.
  • Imamura M; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Hiroshima University, Hiroshima, Japan.
  • Kawakami Y; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Hiroshima University, Hiroshima, Japan.
  • Masaki K; Hiroshima City Asa Hospital, Hiroshima, Japan.
  • Honda Y; Hiroshima Red Cross Hospital, Hiroshima, Japan.
  • Mori N; Hiroshima Red Cross Hospital, Hiroshima, Japan.
  • Takaki S; Hiroshima Red Cross Hospital, Hiroshima, Japan.
  • Tsuji K; Hiroshima Red Cross Hospital, Hiroshima, Japan.
  • Kohno H; Kure Medical Center, Hiroshima, Japan.
  • Kohno H; Kure Medical Center, Hiroshima, Japan.
  • Moriya T; Chugoku Rousai Hospital, Hiroshima, Japan.
  • Nonaka M; Hiroshima General Hospital, Hiroshima, Japan.
  • Hyogo H; Hiroshima General Hospital, Hiroshima, Japan.
  • Aisaka Y; Hiroshima General Hospital, Hiroshima, Japan.
  • Kimura T; Department of Radiation Oncology, Hiroshima University Hospital, Hiroshima, Japan.
  • Nagata Y; Department of Radiation Oncology, Hiroshima University Hospital, Hiroshima, Japan.
  • Chayama K; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Hiroshima University, Hiroshima, Japan.
Oncology ; 94(4): 215-222, 2018.
Article in En | MEDLINE | ID: mdl-29428943

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Phenylurea Compounds / Portal Vein / Antineoplastic Combined Chemotherapy Protocols / Niacinamide / Carcinoma, Hepatocellular / Liver Neoplasms / Antineoplastic Agents Type of study: Observational_studies / Risk_factors_studies Language: En Journal: Oncology Year: 2018 Type: Article Affiliation country: Japan

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Phenylurea Compounds / Portal Vein / Antineoplastic Combined Chemotherapy Protocols / Niacinamide / Carcinoma, Hepatocellular / Liver Neoplasms / Antineoplastic Agents Type of study: Observational_studies / Risk_factors_studies Language: En Journal: Oncology Year: 2018 Type: Article Affiliation country: Japan